According to a study published in the journal Digestive Diseases and Sciences, marijuana consumers with Crohn’s disease who are seeking hospitalization possess fewer disease-related complications compared to those who don’t use cannabis.

For the study a team of investigators from the John H. Stroger Hospital in Chicago, the SUNY Downstate Medical Centre in New York City, and the Digestive Disease Institute in Cleveland assessed the relationship between cannabis use and the prevalence of Crohn’s disease-related complications and clinical outcomes in a nationwide cohort of hospitalized patients.

According to a NORML news release, authors reported that patients with a history of cannabis use possessed fewer complications and experienced better clinical outcomes as compared to abstainers.

They concluded, “In summary, our study suggests that cannabis use may mitigate several of the well-described complications of Crohn’s disease among hospital inpatients and this could be due to an anti-inflammatory effect of cannabis and potential improvement in gastrointestinal mucosal healing.”

A prior observational study “showed that cannabis use is associated with fewer incidences of Crohn’s disease hospitalizations, while a placebo-controlled trial reported that cannabis therapy was associated with greater rates of disease remission”, states NORML.

The full text of the study, “Association between cannabis use and complications related to Crohn’s

Read More Here…